Article
A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone.
Journal of clinical psychopharmacology - 1 Feb 2013
Potkin Steven G, Preskorn Sheldon, Hochfeld Marla, Meng Xiangyi
Abstract excerpt
The potential for iloperidone, a D2/5-HT2A antipsychotic, to affect the heart rate-corrected QT interval (QTc) was assessed in the absence and presence of metabolic inhibitors in a randomized, open-label, multicenter study. QT interval prolongation by medications, including both conventional and atypical antipsychotic drugs, can predispose patients to cardiac arrhythmias and result in sudden death. Adults with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
